Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Veracyte Inc., 3 years.
Veracyte Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Veracyte Inc. | Grant or award | +5,272 | — | — |
| Nov 20, 2025 | Veracyte Inc. | Open-market sale | −1,491 | $40.95 | $61,056 |
| Nov 20, 2025 | Veracyte Inc. | Open-market sale | −7,049 | $42.48 | $299,442 |
| Nov 20, 2025 | Veracyte Inc. | Open-market sale | −1,460 | $43.21 | $63,087 |
| Jun 18, 2025 | Veracyte Inc. | Grant or award | +9,321 | — | — |
| Aug 7, 2024 | Veracyte Inc. | Open-market sale | −2,500 | $28.00 | $70,000 |
| Aug 7, 2024 | Veracyte Inc. | Open-market sale | −2,500 | $30.00 | $75,000 |
| Jul 16, 2024 | Veracyte Inc. | Open-market sale | −2,500 | $24.00 | $60,000 |
| Jul 16, 2024 | Veracyte Inc. | Open-market sale | −2,500 | $25.00 | $62,500 |
| Jun 13, 2024 | Veracyte Inc. | Grant or award | +11,473 | — | — |
| Jun 9, 2023 | Veracyte Inc. | Grant or award | +9,674 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.